Redefining the Management of Diabetes: A Review of Quality and Individualizing Patient Care

Pharmacy Times, June 2015 Women's Health, Volume 81, Issue 6

This Continuing Education activity is supported by an educational grant from AstraZeneca LP and Novo Nordisk, Inc

This activity is supported by an educational grant from AstraZeneca LP and Novo Nordisk, Inc

Redefining the Management of Diabetes: A Review of Quality and Individualizing Patient Care

Faculty

Jennifer Costello, PharmD, BCPS, BC-ADM

Assistant Director of Clinical Services

for the Pharmacy Department

Residency Program Director

Saint Barnabas Medical Center

Livingston, NJ

Educational Objectives

After completing this continuing education program, the participant will be able to:

  • Review clinical practice guidelines and standards of care in the management of type 2 diabetes mellitus.
  • Examine comprehensive treatment plans for patients with diabetes that focus on individualization.
  • Document recommendations, benefits, risks, limitations, and controversies surrounding pharmacologic therapy with insulin.
  • Adopt programs focused on achieving clinical metrics and improving patient outcomes.

Target audience: Pharmacists

Type of activity: Application

Release date: June 7, 2015

Expiration date: June 7, 2017

Estimated time to complete activity: 2.0 hours

Fee: Free

Pharmacy Times Office of Continuing Professional Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 2.0 contact hours (0.2 CEUs) under the ACPE universal activity number 0290-0000-15-050-H01-P. The activity is available for CE credit through June 7, 2017.